• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

5-甲基四氢叶酸水平降低:一种潜在的肌萎缩侧索硬化症症状前生物标志物。

Decreased level of 5-methyltetrahydrofolate: a potential biomarker for pre-symptomatic amyotrophic lateral sclerosis.

作者信息

Zhang X, Chen S, Li L, Wang Q, Le W

机构信息

Insitute of Neurology, Ruijin Hospital, Jiaotong University School of Medicine, Shanghai, China.

出版信息

J Neurol Sci. 2010 Jun 15;293(1-2):102-5. doi: 10.1016/j.jns.2010.02.024. Epub 2010 Mar 23.

DOI:10.1016/j.jns.2010.02.024
PMID:20334883
Abstract

BACKGROUND

Several studies have reported that homocysteine (Hcy) is associated with amyotrophic lateral sclerosis (ALS), a neurodegenerative disease without special biomarkers for early diagnosis. Here, we examined the levels of Hcy, folic acid and its metabolic molecule 5-methyltetrahydrofolate (5-MTHF) in SOD1(G93A) transgenic mouse model of ALS in an attempt to determine whether the change in those molecules can be used as potential biomarkers for the disease.

METHODS

According to the disease progression, SOD1(G93A) transgenic mice were divided into early stage group (30d); pre-symptom group (60d); symptom group (90d) and terminal stage group (120d). LC-MS/MS was used to measure the level of Hcy, folic acid and 5-MTHF in the plasma, spinal cord and cortex of the ALS transgenic SOD1(G93A) mice at different disease stages. Nissl staining was used to detect the motor neurons survival in the anterior horn of the spinal cord of the SOD1(G93A) mice.

RESULTS

In this study, we demonstrated that the level of 5-MTHF is significantly decreased in the plasma, spinal cord and cortex at the early stages of pre-symptomatic ALS transgenic SOD1(G93A) mice while folic acid is decreased at the middle to late stages of the disease. Furthermore, we found that the level of Hcy is markedly elevated after the motor symptoms appeared in the ALS mice.

CONCLUSION

Our study suggests that decreased 5-MTHF level may be a potential biomarker for the early stage of the disease in the ALS mice, which may warrant further validating study of 5-MTHF level in ALS patients.

摘要

背景

多项研究报告称,同型半胱氨酸(Hcy)与肌萎缩侧索硬化症(ALS)相关,ALS是一种没有用于早期诊断的特殊生物标志物的神经退行性疾病。在此,我们检测了ALS的SOD1(G93A)转基因小鼠模型中Hcy、叶酸及其代谢分子5-甲基四氢叶酸(5-MTHF)的水平,以确定这些分子的变化是否可作为该疾病的潜在生物标志物。

方法

根据疾病进展,将SOD1(G93A)转基因小鼠分为早期组(30天);症状前期组(60天);症状组(90天)和终末期组(120天)。采用液相色谱-串联质谱法(LC-MS/MS)测量不同疾病阶段的ALS转基因SOD1(G93A)小鼠血浆、脊髓和皮质中Hcy、叶酸和5-MTHF的水平。采用尼氏染色法检测SOD1(G93A)小鼠脊髓前角运动神经元的存活情况。

结果

在本研究中,我们证明,在症状前期ALS转基因SOD1(G93A)小鼠的早期,血浆、脊髓和皮质中的5-MTHF水平显著降低,而叶酸在疾病的中晚期降低。此外,我们发现ALS小鼠出现运动症状后,Hcy水平显著升高。

结论

我们的研究表明,5-MTHF水平降低可能是ALS小鼠疾病早期的潜在生物标志物,这可能需要对ALS患者的5-MTHF水平进行进一步的验证研究。

相似文献

1
Decreased level of 5-methyltetrahydrofolate: a potential biomarker for pre-symptomatic amyotrophic lateral sclerosis.5-甲基四氢叶酸水平降低:一种潜在的肌萎缩侧索硬化症症状前生物标志物。
J Neurol Sci. 2010 Jun 15;293(1-2):102-5. doi: 10.1016/j.jns.2010.02.024. Epub 2010 Mar 23.
2
Folic acid protects motor neurons against the increased homocysteine, inflammation and apoptosis in SOD1 G93A transgenic mice.叶酸可保护运动神经元,使其免受SOD1 G93A转基因小鼠体内同型半胱氨酸增加、炎症及细胞凋亡的影响。
Neuropharmacology. 2008 Jun;54(7):1112-9. doi: 10.1016/j.neuropharm.2008.02.020. Epub 2008 Mar 16.
3
Reductions of docosahexaenoic acid-containing phosphatidylcholine levels in the anterior horn of an ALS mouse model.肌萎缩侧索硬化症小鼠模型前角中含二十二碳六烯酸的磷脂酰胆碱水平降低。
Neuroscience. 2015 Jun 25;297:127-36. doi: 10.1016/j.neuroscience.2015.03.060. Epub 2015 Apr 2.
4
In vivo quantification of spinal and bulbar motor neuron degeneration in the G93A-SOD1 transgenic mouse model of ALS by T2 relaxation time and apparent diffusion coefficient.通过T2弛豫时间和表观扩散系数对肌萎缩侧索硬化症G93A-SOD1转基因小鼠模型中脊髓和延髓运动神经元变性进行体内定量分析。
Exp Neurol. 2006 Oct;201(2):293-300. doi: 10.1016/j.expneurol.2006.04.007. Epub 2006 Jun 5.
5
Metabolic progression markers of neurodegeneration in the transgenic G93A-SOD1 mouse model of amyotrophic lateral sclerosis.肌萎缩侧索硬化症转基因G93A-SOD1小鼠模型中神经退行性变的代谢进展标志物
Eur J Neurosci. 2007 Mar;25(6):1669-77. doi: 10.1111/j.1460-9568.2007.05415.x.
6
Over-expression of Hsp27 does not influence disease in the mutant SOD1(G93A) mouse model of amyotrophic lateral sclerosis.在肌萎缩侧索硬化症的突变型SOD1(G93A)小鼠模型中,热休克蛋白27(Hsp27)的过表达并不影响疾病。
J Neurochem. 2008 Sep;106(5):2170-83. doi: 10.1111/j.1471-4159.2008.05545.x. Epub 2008 Jul 4.
7
Serum matrix metalloproteinase-9 activity is dysregulated with disease progression in the mutant SOD1 transgenic mice.血清基质金属蛋白酶-9 活性在突变 SOD1 转基因小鼠的疾病进展中失调。
Neuromuscul Disord. 2010 Apr;20(4):260-6. doi: 10.1016/j.nmd.2009.11.015. Epub 2010 Jan 25.
8
Serial in vivo imaging of transplanted allogeneic neural stem cell survival in a mouse model of amyotrophic lateral sclerosis.在肌萎缩侧索硬化小鼠模型中对移植的同种异体神经干细胞存活情况进行的连续体内成像。
Exp Neurol. 2017 Mar;289:96-102. doi: 10.1016/j.expneurol.2016.12.011. Epub 2016 Dec 28.
9
Up-regulation of neural and cell cycle-related microRNAs in brain of amyotrophic lateral sclerosis mice at late disease stage.肌萎缩侧索硬化症小鼠疾病晚期大脑中神经和细胞周期相关微小RNA的上调。
Mol Brain. 2015 Jan 28;8:5. doi: 10.1186/s13041-015-0095-0.
10
Memantine prolongs survival in an amyotrophic lateral sclerosis mouse model.美金刚可延长肌萎缩侧索硬化小鼠模型的生存期。
Eur J Neurosci. 2005 Nov;22(9):2376-80. doi: 10.1111/j.1460-9568.2005.04431.x.

引用本文的文献

1
Nutritional Interventions in Amyotrophic Lateral Sclerosis: From Ketogenic Diet and Neuroprotective Nutrients to the Microbiota-Gut-Brain Axis Regulation.肌萎缩侧索硬化症的营养干预:从生酮饮食和神经保护营养素到微生物群-肠-脑轴调节
Mol Neurobiol. 2025 Mar 17. doi: 10.1007/s12035-025-04830-8.
2
Hyperhomocysteinemia and Disease-Is 10 μmol/L a Suitable New Threshold Limit?高同型半胱氨酸血症与疾病——10 μmol/L 是否是一个合适的新阈值?
Int J Mol Sci. 2024 Nov 15;25(22):12295. doi: 10.3390/ijms252212295.
3
The Spatiotemporal Expression of SOCS3 in the Brainstem and Spinal Cord of Amyotrophic Lateral Sclerosis Mice.
信号转导子和转录激活子3(SOCS3)在肌萎缩侧索硬化症小鼠脑干和脊髓中的时空表达
Brain Sci. 2024 May 31;14(6):564. doi: 10.3390/brainsci14060564.
4
From Environment to Gene Expression: Epigenetic Methylations and One-Carbon Metabolism in Amyotrophic Lateral Sclerosis.从环境到基因表达:肌萎缩侧索硬化症中的表观遗传甲基化和一碳代谢。
Cells. 2024 Jun 3;13(11):967. doi: 10.3390/cells13110967.
5
The level of homocysteine in amyotrophic lateral sclerosis: a systematic review and meta-analysis.肌萎缩侧索硬化症中同型半胱氨酸水平:一项系统评价和荟萃分析。
Neurol Sci. 2023 Apr;44(4):1185-1192. doi: 10.1007/s10072-022-06518-6. Epub 2022 Nov 24.
6
Nutrient Effects on Motor Neurons and the Risk of Amyotrophic Lateral Sclerosis.营养素对运动神经元的影响与肌萎缩侧索硬化症的风险。
Nutrients. 2021 Oct 26;13(11):3804. doi: 10.3390/nu13113804.
7
Association Between Vitamins and Amyotrophic Lateral Sclerosis: A Center-Based Survey in Mainland China.维生素与肌萎缩侧索硬化症之间的关联:中国大陆一项基于中心的调查
Front Neurol. 2020 Jun 18;11:488. doi: 10.3389/fneur.2020.00488. eCollection 2020.
8
Dynamic changes of CX3CL1/CX3CR1 axis during microglial activation and motor neuron loss in the spinal cord of ALS mouse model.肌萎缩侧索硬化症小鼠模型脊髓中CX3CL1/CX3CR1轴在小胶质细胞激活和运动神经元丢失过程中的动态变化。
Transl Neurodegener. 2018 Dec 21;7:35. doi: 10.1186/s40035-018-0138-4. eCollection 2018.
9
Repurposing carbamazepine for the treatment of amyotrophic lateral sclerosis in SOD1-G93A mouse model.重新利用卡马西平治疗 SOD1-G93A 小鼠模型中的肌萎缩侧索硬化症。
CNS Neurosci Ther. 2018 Dec;24(12):1163-1174. doi: 10.1111/cns.12855. Epub 2018 Apr 14.
10
Amyotrophic lateral sclerosis: a focus on disease progression.肌萎缩侧索硬化症:关注疾病进展
Biomed Res Int. 2014;2014:925101. doi: 10.1155/2014/925101. Epub 2014 Aug 3.